Reverse Total Shoulder Arthroplasty: Clinical Updates and Perspectives, Opportunities and Challenges

Dear Colleagues,

With the increasing success of reverse total shoulder arthroplasty (RTSA) over the past decade, the indications for RTSA have expanded from cuff tear arthropathy to other pathologies such as proximal humeral fracture sequelae or eccentric glenohumeral osteoarthritis. Several factors are associated with the increase in use of RTSA including novel implant designs, preoperative planning tools, surgeons’ experience and first studies on long-term results, as well as an increasingly aging population. With this boom of RTSA, the number of failures and revision surgeries will also continue to rise just as RTSA-specific complications including acromial fractures, tuberosity mal-/non-union, glenoid bone loss or instability. As a surgeon in the field of shoulder arthroplasty, it is therefore of tremendous importance to understand the biomechanics and design of available implants and configurations, know the implant specific complications associated with RTSA, and have salvage options in the situation of RTSA failure included in one’s surgical repertory. The aim of this special issue is to review the literature on indication and implant specific outcome, discuss and provide evidence for the potential benefits of preoperative planning tools, to shed light on unsolved problems in RTSA, and to provide a prospect in the field of RTSA.

Dr. Lukas Ernstbrunner
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.